pharmaphorum

JANUARY 13, 2021

Dr Kirsty Wydenbach is an expert medical assessor and the deputy unit manager in the Clinical Trials Unit at MHRA , having joined in 2009. More recently Kirsty has overseen the clinical trial work for COVID-19 and provided regulatory expertise on vaccines both within MHRA but also as part of the government Vaccine Taskforce.

Medical Schools 52

Medical Schools Hospitals Vaccines 52

ISPE

MAY 10, 2023

Sanat’s organization oversees a complex and large network of manufacturing, commercialization, and distribution operations across four different platforms of pharmaceuticals, vaccines, biologics, and animal health with over 20,000 employees in over 22 countries. Sanat has served on Merck’s Executive Committee since 2016.

Vaccines 52

Vaccines 52

pharmaphorum

DECEMBER 2, 2020

Since the turn of the millennium, Pfizer has embarked on a series of mega-mergers, gobbling up Warner-Lambert in 2000, Pharmacia and Upjohn in 2002, Wyeth in 2009, and Medivation in 2016. Like most pharma companies of its size, Pfizer has faced its fair share of controversy as one of the most well-known drugmakers in the world.

Compounding 128

Compounding Vaccines Pharmaceutical Companies Pharmaceutical Companies 128

pharmaphorum

SEPTEMBER 18, 2020

In June 2007, AstraZeneca completed the acquisition of vaccine maker MedImmune, buying its drug-development pipeline for $15.2 Its oncology treatment Arimidex lost exclusivity in the US in 2009, accounting for a sales decrease of 86%, as published in the 2010 annual report.

Vaccines 116

Vaccines Pharmaceutical Companies Pharmaceutical Companies FDA 116

Pharmaceutical Technology

FEBRUARY 1, 2023

RSV researchers at major pharmaceutical companies are currently working to develop new RSV drugs to beat future waves of RSV infection and gain the first RSV vaccine FDA approval. During the 2009–19 period, children in the US ages five years and younger accounted for 58, 000 annual RSV-related hospitalisations and 100–500 annual deaths.

Vaccines 64

Vaccines FDA Pharmaceutical Companies Pharmaceutical Companies 64

pharmaphorum

JULY 14, 2021

He was referring to his business’ share of misconduct related fines that, between 2009 and 2017, topped $342 billion across the US and Europe. It’s killing us.”

Pharmaceutical Companies 105

Pharmaceutical Companies Pharmaceutical Companies Communication Vaccines 105

PharmaShots

FEBRUARY 21, 2023

Market Cap: $8.57M Founded Year: 2009 Total Employees: ~40 Headquarters: Oslo, Norway Stock Exchange: OSE Nordic Nanovector is a biotech company committed to developing and commercializing antibody-radionuclide conjugates to address significant unmet medical needs. In Aug’21, the US FDA cleared QSam’s IND application for CycloSam.

FDA 56

FDA Dosage Pharmaceutical Companies Pharmaceutical Companies 56

pharmaphorum

OCTOBER 24, 2022

Exemptions include exceptional central procurements, centrally procured vaccines, small company sales, and low-value sales (when the NHS list price is less than £2). For company bottom lines, it matters just what sales this rebate applies to, since the deal also sets out when the rebates don’t apply.

Vaccines 75

Vaccines 75

European Pharmaceutical Review

SEPTEMBER 22, 2023

Active anti-Abeta immunotherapies In the 2000s, the concept of active immunotherapy targeting Abeta in Alzheimer’s patients was assessed with the ELAN vaccine (AN1792), consisting of full-length aggregated Abeta 1-42 peptide mixed with the QS21 adjuvant. 8 However, as this trial was not placebo-controlled, conclusions are difficult to draw.

Immunization 75

Immunization Vaccines Communication Labelling 75

The Checkup by Singlecare

NOVEMBER 30, 2023

Acetaminophen may also blunt the effects of other medications that impact the immune system, including some medicines used to manage cancer diagnoses and even the immune response following vaccinations. However, studies have concluded that using acetaminophen after vaccination to treat fever or pain did not affect antibody response.

Immunization 98

Immunization Vaccines FDA Labelling 98

pharmaphorum

JANUARY 5, 2021

Anyone who proposed that a novel, deadly virus would spread, with a vaccine developed demonstrating 95% efficacy, and approved for patients in less than a year would have been scoffed at. These changes are likely to reduce only slowly in the Vaccine+ environment, and will not be entirely reversed.

Hospitals 105

Hospitals Vaccines Pharmaceutical Companies Pharmaceutical Companies 105

ISPE

MARCH 8, 2023

6 , 13 , 14 The most commonly mentioned contaminants were Burkholderia species 5 , 8 as a whole, and vesivirus 2117 for Genzyme products in 2009. Noteworthy cases were the inadvertent introduction of grade 316L stainless steel into Moder-na’s COVID-19 vaccine by the outsourced manufacturer (ROVI Pharma Industrial Services S.

Compounding 52

Compounding Compounding Pharmacies Packaging FDA 52

PharmaShots

FEBRUARY 20, 2023

However, upstream production in plants must also comply with additional laws relating to environmental release if grown outdoors (Directive 2001/ 18/EC, and 1829/2003/EC if the crop can be used as food/ feed) and Directive 2009/41EC if grown in constraint. However, these VLPs do not contain genetic material, making them non-infectious.

Vaccines 40

Vaccines Pharmaceutical Companies Pharmaceutical Companies Compounding 40

pharmaphorum

FEBRUARY 16, 2021

President Joe Biden asked Slaoui to step down as chief scientific adviser to the US COVID-19 vaccine initiative after the White House administration changed late last month and the former GlaxoSmithKline research chief wasted no time in finding a new project.

Vaccines 59

Vaccines Pharmaceutical Companies Pharmaceutical Companies 59

PharmaShots

APRIL 13, 2023

2009 was a challenging year for multinational companies due to the recession and currency fluctuations Johnson & Johnson's performance graph declined by 2.9% Despite a challenging year, Johnson & Johnson acquired Cougar and Elan Pfizer's 2009 performance was significant as compared to 2008 with the addition of Wyeth.

Vaccines 40

Vaccines Pharmaceutical Companies Pharmaceutical Companies Labelling 40

pharmaphorum

FEBRUARY 26, 2021

The litigation was settled in 2009, when Boston Scientific agreed to pay $716 million in September and an additional $1.73 Beginning in 2003, J&J became involved in a series of litigations with Boston Scientific involving patents covering heart stent medical devices. Both parties claimed that the other had infringed upon their patents.

Vaccines 126

Vaccines Labelling Communication 126

Pharmaceutical Technology

AUGUST 26, 2008

We are now one of the ten largest biopharma companies in the world with a rich armoury of new technology, comprising a full suite of technologies, small molecules, antibodies and vaccines to create new human medicines.” The blood pressure results are expected in the first half of 2009.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Vaccines Immunization 52

pharmaphorum

MARCH 30, 2021

She says she is “truly amazed” about what the industry has achieved in such a short time when it comes to innovations, vaccines and treatments. “When we come together like this, innovation can happen a lot faster.”. About the author.

Hospitals 111

Hospitals Communication Pharmaceutical Companies Pharmaceutical Companies 111

The Checkup by Singlecare

JANUARY 12, 2023

A fear of needles ( trypanophobia) causes up to 16% of adults to avoid getting vaccines. Journal of Affective Disorders , 2009). Nearly 35% of a study of 1,001 patients with obsessive-compulsive disorder (OCD) also had a social phobia. Journal of Affective Disorders , 2012). Cleveland Clinic , 2022). Cleveland Clinic , 2022).

Vaccines 52

Vaccines 52

pharmaphorum

FEBRUARY 5, 2021

One high-profile project has been the use of real-world data during the approval of COVID-19 vaccines, something that she discussed in an emailed interview with pharmaphorum earlier in the pandemic. Hahn had to fight off pressure from the Trump administration to approve Pfizer’s vaccine early.

FDA 119

FDA Vaccines Labelling 119

Pharmaceutical Technology

MARCH 22, 2023

During the Covid-19 pandemic, large-scale vaccine production placed unprecedented demand on the parenteral packaging industry. While production volumes have now fallen, future vaccine demand is hard to predict, as booster shots could be needed at any point to control emerging variants.

Packaging 52

Packaging Compounding Pharmaceutical Companies Pharmaceutical Companies 52